SUBSCRIBE
SUBSCRIBE
News   Business

The Structure of BioAlliance Pharma’s Turnover for Q3 2010 Reflects the Dynamism of the Company’s American and European Collaborations

October 21, 2010 | 
1 min read
PARIS--(BUSINESS WIRE)--Regulatory News : BioAlliance Pharma SA (Paris:BIO), a company dedicated to the supportive care and treatment of cancer patients, today announced a consolidated turnover of €0.9 million for the third quarter of 2010.
Earnings Europe
MORE ON THIS TOPIC
Illustration of employer’s hand holding employee who was laid off to drop him out of office
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
June 30, 2025
 · 
1 min read
 · 
Tristan Manalac
Themis with sword and scales in cyberspace. Ai regulation, artificial intelligence and law issues concept. Vector illustration.
Legal
Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force
June 27, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong